Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05165758
Other study ID # 21_RIPH3-04
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 21, 2022
Est. completion date June 17, 2022

Study information

Verified date September 2022
Source University Hospital Center of Martinique
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to compare quality of life of diabetics with and without foot ulcer. Investigators will compare their quality of life based on the mental health impact of foot ulcer.


Description:

Diabetes is one of the most frequent pathologies in Martinique (French West Indies) in terms of prevalence, as are its complications. The diabetic foot ulcer is a real public health problem considering its impact on the island. It has already been shown that diabetic patients have a lower quality of life than the overall population. It is now time to compare the quality of life of diabetics with and without foot ulcer in Martinique. Such a complication has a social impact that should not be overlooked in primary, secondary and tertiary prevention.


Recruitment information / eligibility

Status Completed
Enrollment 81
Est. completion date June 17, 2022
Est. primary completion date June 17, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - People of 18 years old and over, - Diabetics living in Martinique, - Patient having been informed of the research, - Patient agreeing to participate in the study. Exclusion Criteria: - Minor patient, - Hospitalized patients during inclusion phase, - Patients with confusional syndrome, - Patient presenting a cognitive state making it difficult to complete the questionnaire, - Patient under legal protection, under guardianship or under curatorship, - Patient who refused to participate in the study.

Study Design


Intervention

Other:
Self-assessment questionnaires
Subjects will pass the SF-36 score (mental health items) and the EPICES index

Locations

Country Name City State
France University Hospital Center of Martinique Fort-de-France Martinique

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Center of Martinique

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compare the levels of quality of life in diabetic subjects with and without foot ulcer The primary endpoint will be the score on the mental health dimension of the SF-36 score 6 months
Secondary Compare the levels of precarity in diabetic subjects with and without foot ulcer To evaluate the level of precarity, the EPICES score will be calculated for both type of subjects. 6 months
Secondary Compare the levels of quality of life according to the levels of HbA1c, in diabetic subjects with and without foot ulcer To evaluate the level of quality of life according to HbA1c, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects. 6 months
Secondary Compare the quality of life levels according to the duration of diabetes, in diabetic subjects with and without foot ulcer To evaluate the level of quality of life according to the duration of diabetes, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects. 6 months
Secondary Compare the quality of life levels according to the type of antidiabetic treatment, in diabetic subjects with and without foot ulcer To evaluate the level of quality of life according to the antidiabetic treatment, the score of the mental health dimension of the SF-36 questionnaire will be calculated for both type of subjects. 6 months
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4